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Techniques of protein regulation, such as conditional gene expression, RNA interference,
knock-in and knock-out, lack sufficient spatiotemporal accuracy, while optogenetic tools
suffer from non-physiological response due to overexpression artifacts. Here we present a
near-infrared light-activatable optogenetic system, which combines the specificity and
orthogonality of intrabodies with the spatiotemporal precision of optogenetics. We engineer
optically-controlled intrabodies to regulate genomically expressed protein targets and vali-
date the possibility to further multiplex protein regulation via dual-wavelength optogenetic
control. We apply this system to regulate cytoskeletal and enzymatic functions of two non-
tagged endogenous proteins, actin and RAS GTPase, involved in complex functional networks
sensitive to perturbations. The optogenetically-enhanced intrabodies allow fast and reversible
regulation of both proteins, as well as simultaneous monitoring of RAS signaling with visible-
light biosensors, enabling all-optical approach. Growing number of intrabodies should make
their incorporation into optogenetic tools the versatile technology to regulate endogenous
targets.
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Precise control of protein activity and protein–proteininteractions is in high demand. Common techniques ofprotein regulation, such as conditional gene expression,
RNA interference, knock in, and knock out, partly meet this
demand, however, often do not provide sufficient spatial or
temporal precision1. Antibody-like recombinant binders func-
tional within mammalian cells, generally termed as intrabodies
(iBs), were shown to be a powerful technology aimed to regulate
protein activity. Small (13–25 kDa)2 and highly affine (from nM
to low µM)3 iBs can be used for allosteric protein regulation,
manipulating protein functionality, and for target degradation4.
Constructs exploiting recombinant binders were used for T-cell-
receptor-like signaling reconstruction in nonimmune cells5 and
for reprogramming of cells into pluripotent stem cells6, demon-
strating iBs performance in complex synthetic biology applica-
tions. More than 3 × 106 antibodies covering about 90% of human
proteome7, and about 1.5 × 103 single-domain antibodies8,
potentially used as iBs, are currently reported. Several approaches
for selection of specific iBs from libraries9 and for their rational
design10 should make the binders available to almost any cellular
protein.
A possibility to switch iBs on and off should advance their
functionality. In active (on) state, the knock-out11–13 function can
be achieved with minimal disturbance, at specific environment
and time point. Inactive (off) state can help to avoid off-target
influence14 by restricting the spatiotemporal binder activity to
reduce unwanted interactions.
Natural photoreceptors provided a variety of approaches to
design molecular switches, enabling control of protein functions
by light15. Among these, bacterial phytochromes, sensitive to near-
infrared (NIR) light, cryptochromes, and LOV domains, sensitive
to blue light, do not need supply of exogenous cofactors to effi-
ciently function in mammalian cells. The distinct spectral sensi-
tivity of these photoreceptors allows their effective spectral
multiplexing16. The light-dependent structural reorganization,
homo- and heterodimerization of these non-opsin photoreceptors
were successfully applied to gene expression, regulation of its
epigenetic state, control of cell signaling, cell cycle progression,
and apoptosis. Blue-light-mediated genome editing was reported
recently17. The non-opsin optogenetic tools are used in cultured
cells of various origin18, in primary cell cultures19 and in vivo20.
Although the optogenetic systems to regulate protein–protein
interactions demonstrated high spatiotemporal precision and large
dynamic range of responces21,22, they usually control functions of
the overexpressed exogenous proteins. The protein overexpression
may result in nonphysiological response, abnormal localization, or
aggregation23, and suffer from competition with endogenous
protein, requiring knocking out the latter by siRNA24.
Here, to control native cellular physiology, we integrate dif-
ferent types of iBs, such as nanobodies and monobodies, into NIR
and blue-light-activatable optogenetic tools. We thoroughly test
compatibility of iBs and optogenetic tools in mammalian cells.
We next apply the optogenetic tools merged with iBs to regulate
genomically encoded proteins. We show the versatility of this
approach by the use of two spectrally resolved optogenetic tools
for tridirectional targeting of an endogenous protein. Next, the
dual-wavelength optogenetic system for protein localization is
applied to regulate cell motility and nuclear actin function. Lastly,
we combine the light regulation of endogenous enzymatic activity
at one wavelength with a readout of the downstream signaling at
another one using spectrally compatible biosensors.
Results
Combining iBs with optogenetic system. To design a light-
sensitive construct with iB we fused a bacterial phytochrome
from Rhodopseudomonas palustris BphP1 (ref. 25) to anti-GFP
iB vhhGFP4 (ref. 26), hereafter referred as iB(GFP). iB(GFP) binds
with high affinity A. victoria’s GFP-derived fluorescent proteins,
but not mCherry. BphP1 is a light-sensing component of the
heterodimerization optogenetic system consisting of the BphP1
and QPAS1 interacting proteins. Upon absorbing 740–780 nm
light, BphP1 undergoes photoconversion into an activated state,
resulting in the binding of QPAS1. We monitored this interaction
in HeLa cells co-expressing BphP1-iB(GFP), mVenus-CAAX, and
mCherry-QPAS1. In darkness, mCherry-QPAS1 localized in
cytoplasm. Under NIR light of 740 nm, the mCherry-QPAS1
relocalized to plasma membrane (Fig. 1a, b, Supplementary
Figs. 1a and 2). This showed the possibility of light-triggered
recruitment of a protein of interest to certain subcellular location
using its specific interaction with a recombinant binder. To fur-
ther characterize this interaction, we studied the kinetics of
mCherry-QPAS1 relocalization. The fluorescence signal in cyto-
plasm decreased with a half-time of 33.6 s (Supplementary
Fig. 1b), which was similar to that for interaction of non-fused
membrane-targeted BphP1 and QPAS1 (ref. 27).
Targeting genomically encoded protein with iB. Since the
expression level of interacting proteins may affect the binding
efficiency and kinetics, we further tested iB performance in
light-triggered targeting of a genomically encoded EGFP-tagged
protein. For this, we established a preclonal mixture of
HeLa cells stably expressing EGFP-tagged puromycin N-
acetyltransferase (EGFP-PAC) and cotransfected them with
BphP1-iB(GFP) and NES-mCherry-QPAS1-NLS. The NES and
NLS signals were added to mCherry-QPAS1 to facilitate its
shuttling between nucleus and cytoplasm, with the equilibrium
shifted to the nucleus, similarly to described28 (Fig. 1c, d). In
darkness, EGFP-PAC was distributed evenly in nucleus and
cytoplasm, being bound to BphP1-iB(GFP). Under 740 nm illu-
mination, BphP1-iB(GFP) interacted with mCherry-QPAS1,
resulting in substantial increase of EGFP-PAC in the nucleus,
driven by strong NLS sequence of mCherry-QPAS1 (Fig. 1c, d,
Supplementary Figs. 1c and 3). Kinetics of this process was slower
(t1/2= 1890 s) than that for the relocalization from the cytoplasm
to the plasma membrane (Supplementary Figs. 1d and 3), likely
reflecting its dependence on the nuclear transport machinery and,
consequently, on the size of the optically controlled construct
itself (in this case BphP1-iB(GFP), ~95 kDa) and the cargo pro-
tein (EGFP-PAC, ~48 kDa).
To test a possibility to light-control the opposite process, such as
a release of a protein caged in nucleus to cytoplasm, iB(GFP) was
fused to mCherry-QPAS1 and the NLS and NES sequences were
added for nuclear-cytoplasmic shuttling, shifted to the nucleus in
darkness. NES-tagged BphP1 was used to change the localization
of iB(GFP)-mCherry-QPAS1 under NIR light (Fig. 1e, f). In
darkness, iB(GFP)-mCherry-QPAS1 was predominantly localized
in the nucleus, whereas under 740 nm light, due to interaction with
strongly cytoplasmic NES-BphP1, both iB(GFP)-mCherry-QPAS1
and EGFP-PAC relocalized to cytoplasm with a half-time of 504 s
(Supplementary Fig. 1e, f).
These results show the possibility to light-control subcellular
localization of a genomically expressed protein, which can be
used, for example, for optical regulation of knocked-in proteins in
cell lines generated using CRISPR-Cas9 system29,30.
Three-directional targeting of endogenous proteins. Combin-
ing optogenetic tools controlled by light of different wavelengths
enabled tridirectional protein targeting27, which may be used to
control multifunctional proteins or to increase dynamic range of
bidirectional localizers, as discussed31. A NIR-blue-light inducible
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shuttle (iRIS) construct was shown to be effective for dual-
wavelength-controlled exogenous protein relocalization16,19. In
this system, the QPAS1 protein is fused to a blue-light-sensing
AsLOV2-based nuclear localization controller. AsLOV2 carries
NLS, which is caged in darkness but becomes accessible after 460
nm illumination, leading to the iRIS accumulation in the nucleus.
Under 740 nm light, QPAS1 is interacting with the plasma
membrane-anchored BphP1 protein, driving the iRIS to the
membrane. Under “drive” or “targeting” we mean the major shift
in the equilibrium toward certain compartment, taking into
account that the protein of interest is always observed in all
compartments but at considerably different concentrations. Here,
for tridirectional targeting of genomically expressed proteins, we
combined the iRIS with iB(GFP) to make a NES-iB(GFP)-
mCherry-QPAS1-AsLOV2cNLS system, termed iRIS-B (Fig. 2,
Supplementary Fig. 4, Supplementary Note 1).
β-actin was reported to be involved in a variety of processes
linked to different cellular compartments32. Being responsible for
vast number of protein–protein interactions, actin is especially
sensitive to invasiveness of the approach used to detect or control
it. Overexpression of GFP-tagged actin was shown to rise artefacts
due to disturbance of normal actin arrangement33. For accurate
perturbation of endogenous β-actin, we used GFP-labeled
camelid iB (iB(actin))34 that minimally interferes with normal
actin dynamics33. To target both nuclear and cytoplasmic actin
functions, we apply the iRIS-B system to drive iB(actin) and,
subsequently, to cause actin relocalization (Fig. 3a). We
cotransfected HeLa cells with iRIS-B and iB(actin), and followed
actin arrangement in darkness, under 460 and 740 nm light. In
darkness, mCherry signal of iRIS-B and GFP signal from iB(actin)
were colocalized with cortical actin and stress fibers (Fig. 3b–d,
Supplementary Figs. 5 and 6), with the signal excluded from
nucleus. After 460 nm illumination, amount of iB(actin) in the
nucleus notably increased (Fig. 3b, f, Supplementary Fig. 6a),
nucleoli become visible being highlighted by the signal in
nucleoplasm. In turn, after 740 nm illumination, green signal
disappeared from stress fibers, concentrating predominantly at
the plasma membrane (Fig. 3c–e, Supplementary Figs. 5 and 6b).
To ensure the targeting of endogenous actin bound to
iB(actin), we introduced an additional light-independent probe
for actin visualization. For this, we cotransfected cells with
iB(actin), iRIS-B, and LifeAct-miRFP703. The cells illuminated
with 740 nm, 460 nm, or kept in darkness were fixed and stained
with DAPI. The fluorescence signals were distributed (Fig. 4a) in
accordance to the scheme in Fig. 3a, with LifeAct-miRFP703
colocalized with iB(actin), confirming the relocalization of
endogenous β-actin. The background signal at stress fibers
suggests that mainly the monomeric actin pool was affected by
relocalization.
To make certain that the iRIS-B–iB(GFP) complex enables the
same functionality as a direct iRIS-iB(actin) fusion, we swapped
iB(GFP) for iB(actin) in the iRIS-B. The resulting construct was
designated as an iRIS-Ba where “a” stands for “actin.” We then
imaged iRIS-Ba in live cells under blue and NIR light (Fig. 3g)
and in fixed cells in which β-actin was visualized with LifeAct as a
light-independent probe (Fig. 4b). In both cases the iRIS-Ba
showed the same phenotype as the iRIS-B–iB(actin).
This demonstrated the versatility of iRIS-B, since iRIS-B can be
combined with other fluorescently-tagged iBs, enabling the
functionality comparable to that achieved by direct fusion. In
this way, the approach can be extended to target other
endogenous proteins.
Optical regulation of nuclear actin functions. To study whether
actin targeting to nucleus has functional implications, we
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Fig. 1 Engineering intrabodies to enable their optogenetic control. a Schematic representation of light-induced recruitment of QPAS1-mCherry to the
target protein bound to membrane, where interaction with membrane-bound mVenus occurs via intrabody (iB) fused to BphP1. b Relocalization of QPAS1-
mCherry to plasma membrane under 740 nm illumination. Epifluorescence microscopy; scale bar, 10 µm. c Schematic representation of genomically
expressed EGFP-PAC relocalization from cytoplasm to the cell nucleus upon illumination. d EGFP-PAC relocalization in cells expressing BphP1-iB(GFP) and
NES-mCherry-QPAS1-NLS. In darkness, the QPAS1 fusion is shuttling between nucleus and cytoplasm, driven by strong NLS and weak NES. Upon 740 nm
illumination, it interacts with BphP1 and recruits EGFP-PAC into the nucleus. Epifluorescence microscopy; scale bar, 10 µm. e Schematic representation of
nucleus-to-cytoplasm relocalization of genomically expressed GFP-fusion using NIR light-controlled intrabody. f Cells expressing genomically EGFP-PAC
and transiently BphP1-NES and iB(GFP)-NES-mCherry-QPAS1-NLS. Under 740 nm illumination, EGFP-PAC accumulates in the cytoplasm. Epifluorescence
microscopy; scale bar, 10 μm. Fluorescence intensity profiles corresponding the dashed lines in b, d, and f are shown in Supplementary Fig. 1.
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examined subcellular localization of myocardin-related tran-
scription factor A (MRTF-A), which is a transcription cofactor of
serum response factor. Binding of monomeric actin to the RPEL-
domain of MRTF-A regulates nucleocytoplasmic shuttling of
MRTF-A by inhibiting its nuclear import and enhancing nuclear
export35.
We illuminated serum-starved U2OS cells co-expressing the
iRIS-B and iB(actin) with 460 nm light to enrich actin in nucleus,
as in (Figs. 3b, f and 4a). The cells were then stimulated with
serum, fixed, and MRTF-A subcellular localization was examined
by immunostaining. In the serum-starved conditions (Fig. 5a,
upper panel), MRTF-A was mainly cytoplasmic, as reported
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Fig. 3 Spectral multiplexing allows targeting of both cytoplasmic and nuclear actin. a Schematic representation of dual-wavelength light-controlled
perturbation of endogenous non-tagged actin by iB(actin)–iRIS-B system. b Optical control of iB(actin) localization in cells transfected with iRIS-B. In
darkness, intrabody highlights cortical actin, stress fibers, and is excluded from the nucleus. Under blue light, iB(actin) concentration is increased in
nucleus. Epifluorescence microscopy; scale bar, 10 μm. c In cells analogous to those shown in b, under NIR light, iB(actin) disengages from stress fibers and
cytoplasmic structures and binds plasma membrane due to interaction with BphP1-CAAX. Epifluorescence microscopy; scale bar, 10 μm. Intensity profiles
of fluorescence signals in cell expressing iB(actin), black line, and iRIS-B, red line, before (d) and after (e) 740 nm illumination. Respective epifluorescence
microscopy image is provided in Supplementary Fig. 6b. Source data are provided as a Source Data file. f iB(actin) accumulation in nucleus under 460 nm
illumination. Ratios averaged from five regions of interest from image shown in Supplementary Fig. 6a. Error bars represent SEM, **p < 0.01 (two tailed,
Student’s t test). Source data are provided as a Source Data file. g Cells transfected with iRIS-Ba construct in which the system for tridirectional protein
targeting (iRIS) is fused to iB(actin) directly. Under blue light, iRIS-Ba concentration is increased in the nucleus; under NIR light, iRIS-Ba is observed at
plasma membrane due to its interaction with BphP1-CAAX, similar to iRIS-B. Epifluorescence microscopy; scale bar, 10 μm.
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earlier;35 and the 460 nm illumination almost did not affect its
localization. However, in the serum-stimulated conditions
(Fig. 5a, lower panel, Supplementary Fig. 7), MRTF-A was less
nuclear in cells illuminated with 460 nm light than in cells kept in
darkness. In agreement with previous studies showing that the
actin binding to MRTF-A is required for its nuclear export35, the
increased nuclear actin stimulated the nuclear export of MRTF-A
(Fig. 5b, c).
These experiments further demonstrated that the iRIS-B
system can be efficiently used to study compartment-specific
functions of endogenous β-actin.
Optical control of cell motility via endogenous actin. An ability
to regulate endogenous cytoplasmic β-actin could provide a new
approach to perturb cell motility (Fig. 5d). We cotransfected
HeLa cells with iB(actin) and iRIS-B and imaged random cell
motion in serum for 2400 s (Fig. 5e, f). In darkness, mCherry-
iRIS-B localized similar to the F-actin distribution visualized
through the iB(actin) GFP channel (Fig. 5e, Supplementary
Movie 1). Upon 740 nm illumination, started at 600 s of cell
imaging, the cellular distribution of mCherry-iRIS-B shifted from
the F-actin-like to a punctuated distribution that is reminiscent of
the plasma membrane localization (Fig. 5e, Supplementary
Movie 1). This was corroborated by control experiments in which
the iB(actin) was omitted from co-transfection, but cells were
optogenetically activated to undergo the cytoplasm-to-plasma
membrane transition of iRIS-B (Fig. 5e, Supplementary Movie 2).
We quantified the absolute value of the rate of cell area change
during random motility driven by serum and with 740 nm
optogenetic control of endogenous actin compared with the
control without targeting of actin (Fig. 5f, g). The results indi-
cated an immediate reduction in the ability of cells to move the
edge efficiently (both in protrusion and in retraction) after
switching on 740 nm light (600–2400 s), which reached a max-
imum and highly significant attenuation (p < 0.01 (two tailed,
Student’s t test)) by 1800–2400 s (Fig. 5f, g). Changes in the edge
motion dynamics is visualized and quantified by computationally
tracking the edge (Supplementary Fig. 8, Supplementary Movies 3
and 4), resulting in visible differences in the motility dynamics of
cells when 740 nm is irradiated together with co-expressions of
iRIS-B and iB(actin).
These results show that the light-controlled perturbation of
endogenous cytoplasmic actin by the orthogonal optogenetic tool
impacts the protrusive dynamics and cell motility.
Engineering of optogenetic control of endogenous GTPase. To
study an ability to light-control of cellular endogenous enzymes,
we next designed NIR-sensitive constructs combining an iB and a
BphP1-QPAS1 optogenetic system for nucleus-to-cytoplasm
relocalization. We chose an NS1 monobody specific to RAS
GTPase36 (hereafter iB(RAS)), a well-characterized membrane-
bound oncogenic protein. iB(RAS) was shown to allosterically
regulate activity of the H- and K-RAS isoforms.
iB(RAS), which was fused to mCherry-QPAS1 and tagged with
strong NLS and weak NES tags for nucleocytoplasmic shuttling,
had localization substantially shifted to the nucleus. iB(RAS)-
mCherry-QPAS1 was further cloned after NES-tagged BphP1 via
T2A self-cleavable peptide. In this way, BphP1 activated by NIR
light caused a traction that shifted the nucleus-to-cytoplasm
equilibrium of iB(RAS) toward the cytoplasm (Fig. 6a). Testing of
the resulting construct showed the accumulation of iB(RAS) in
the cytoplasm with a half-time of 516 s and its recovery in
darkness with a half-time of 690 s (Fig. 6b–d, Supplementary
Note 2). Next, we studied if optically controlled iB(RAS) could
recognize its target. For this, mEGFP-HRAS fusion was co-
expressed with iB(RAS). Similar to the initial tests, iB(RAS)
accumulated in the nucleus in darkness. Under 740 nm light, it
was released to the cytoplasm and highlighted the membrane
structures, being colocalized with mEGFP-HRAS (Fig. 6e–g,
Supplementary Fig. 9). This demonstrated that the binding
properties of anti-RAS iB were not affected due to integration
into the light-sensitive system. Importantly, we observed a very
low background signal from iB(RAS) in the cytoplasm before NIR
illumination.
Next, the optically controlled iB(RAS) was imaged with its
endogenous target. For this, cells kept in darkness, after 1800 s of
740 nm illumination, and after 1800 s of 740 nm illumination
followed by 1800 s of darkness, were fixed and stained with anti-
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system and light-independent probe for actin visualization (LifeAct-miRFP703 fusion) on plasma membrane (740 nm), on stress fibers and in cytoplasm
(darkness), and in the nucleus (460 nm). Arrows indicate compartments highlighted by all three probes. Confocal microscopy; scale bar, 10 μm.
b Colocalization of iRIS-Ba and light-independent probe for actin visualization (LifeAct-miRFP703 fusion) on plasma membrane (under 740 nm), on stress
fibers and in cytoplasm (in darkness), and in the nucleus (under 460 nm). Arrows indicate regions highlighted by both iRIS-Ba and LifeAct. Confocal
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pan-RAS monoclonal antibody (mAb). Endogenous RAS was
observed predominantly near the cell perimeter (Fig. 7a,
Supplementary Fig. 10), with high concentration in the cell
ruffles, which was in accordance with the published data37,38.
iB(RAS)-mCherry-QPAS1 under illumination showed mostly
even cytoplasmic distribution, with slightly higher signal in cell
ruffles where anti-RAS mAbs were concentrated (Fig. 7a). Under
NIR light, cells with uncaged iB(RAS) showed less RAS at the
plasma membrane than nontransfected cells. These results were
in accordance with the original iB(RAS) paper36 and abundance
of RAS isoforms in HeLa cells39. Importantly, simultaneous
visualization of iB(RAS)-mCherry-QPAS1 with endogenous RAS
stained with mAbs allowed to exclude their colocalization in
darkness. Under NIR illumination, iB(RAS)-mCherry-QPAS1
concentration in cytoplasm increased, enabling access to RAS. To
additionally verify the interaction between endogenous RAS and
iB(RAS), we imaged the same samples using confocal microscopy.
We observed the similar distribution pattern of RAS (visualized
by immunostaining) and iB(RAS) after its release to the
cytoplasm under 740 nm light (Fig. 7b). After dissociation of
the BphP1-QPAS1 complex during dark relaxation (bottom row
in Fig. 7a) and subsequent iB(RAS)-mCherry-QPAS1 depletion
from cytoplasm, the RAS and iB(RAS) interaction seems not
likely.
The distinct iB(RAS)-mCherry-QPAS1 and RAS distributions
(even cytoplasmic versus dotted, respectively) were likely caused
by different affinities of iB(RAS) and mAbs to different RAS
isoforms and possible competitive binding of iB(RAS) and mAbs.
Optical regulation of endogenous GTPase signaling. We next
studied whether cell signaling can be perturbed via allosteric
inhibition of endogenous RAS by optically controlled iB(RAS).
The RAS-initiated mitogen activated protein kinase (MAPK)
pathway culminates in transcriptional regulation by activated
extracellular-signal regulated kinase (ERK)40,41. Subcellular
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localization of ERK depends on phosphorylation, therefore,
fluorescently labeled ERK localization is used as a readout of
MAPK pathway activity42. We hypothesized that light-driven
inhibition of RAS by iB(RAS) should influence the MAPK sig-
naling in serum-starved HeLa cells under acute stimulation by
epidermal growth factor (EGF).
To test this, HeLa cells co-expressing light-controlled iB(RAS)
and GFP-ERK2 were stimulated with EGF either in darkness or
after 1200 s of NIR illumination. Cells expressing only GFP-ERK2
reporter, but not optogenetic controller (designated as iB(RAS)–),
were used for the estimation of the system dynamic range. For this,
ERK activation level was probed in darkness, after EGF
stimulation, in presence or absence of 500 nM trametinib, which
is potent inhibitor of MEK43. In optogenetically regulated cells, in
darkness, EGF triggered the prompt relocalization of GFP-ERK2 to
the nucleus, with peak activation within first ~720 s of stimulation
(Fig. 8a, b), as previously described43. After this, MAPK activity
slowly decreased. In contrast, in preilluminated cells, EGF-
stimulated ERK activity was substantially lower, reaching a plateau
at twice-lower level as compared with cells in darkness, and
remaining at this level for at least 1000 s (Fig. 8a, b). Importantly,
the EGF activation level in iB(RAS)– cells was close to that of the
iB(RAS)-expressing cells in darkness, showing the effectiveness of
iB caging in the nucleus. We concluded that optogenetic control of
iB(RAS) enables regulation of MAPK signaling.
To probe a long-term effect from RAS signaling inhibition, we
monitored viability of HeLa cells expressing iB(RAS)-mCherry-
QPAS1 in darkness and under NIR light using flow cytometry. RAS
inhibition is a well-known trigger of cell death in various cancer cell
lines, including HeLa44. Indeed, the long-term 740 nm illumination
decreased the survival rate of cells expressing iB(RAS), likely due to
the RAS inhibition (Fig. 8c), additionally proving the functional
activity of optogenetically controlled iB(RAS).
All-optical control of endogenous enzymatic activity. To fur-
ther characterize the optogenetic modulation of endogenous RAS
by iB(RAS), we chose a biosensor for ERK activity, EKAR2G2, to
monitor ERK-mediated phosphorylation downstream of RAS
signaling subnetwork. EKAR2G2 is based on the Förster reso-
nance energy transfer (FRET) between cyan and yellow fluor-
escent proteins45 and reports the local cellular equilibrium of
phosphorylation activity by ERK and dephosphorylation activity
by cellular phosphatases. By monitoring the FRET/donor ratio
from EKAR2G2 one may infer the ability of ERK to phosphor-
ylate its target substrate45.
First, we chose to determine an effect of optogenetic release of
RAS-bound iB(RAS) in HeLa cells in serum under steady-state
conditions (Fig. 9a–c, Supplementary Figs. 11 and 12, Supplemen-
tary Movies 5–7). Upon 740 nm irradiation, the FRET/donor ratio
of EKAR2G2 decreased rapidly as a function of time (t1/2 ~450 s)
to reach a plateau (Fig. 9b). The reduction of FRET/donor ratio
indicated a relative loss of the ability of ERK to phosphorylate its
substrate when the iB(RAS) was released from the nuclear
sequestration. Conversely, when cells were irradiated at 740 nm
for 2400 s prior to the start of EKAR2G2 imaging (740 nm light
was then switched off), the ability of ERK to phosphorylate its
substrate partially recovered and approached an elevated plateau
during the dark relaxation (Fig. 9a, b). The rate of recovery during
the dark relaxation (half-time of 750 s) was slower as compared
with the rate of inhibition from the light-induced release. The
extent of recovery also did not reach the full steady-state levels,
suggesting either an inefficient re-shuttling of iB(RAS) into the
nucleus or that activated ERK may negatively feedback to attenuate
the pathway at RAF/MEK while attaining homeostatic equili-
brium41 (Fig. 9f). We also determined the total dynamic range of
ERKAR2G2 under steady-state conditions using MEK inhibitor
trametinib (500 nM), which led to RAS-ERK downregulation
comparable to those triggered by optogenetics (Supplementary
Fig. 12), confirming efficient performance of iB(RAS).
Next, we followed an activity of another RAS-driven signaling
subnetwork, RAS-Akt, using an AktAR2 FRET biosensor. In
contrast to the RAS-ERK, the RAS-Akt signaling did not show
significant recovery in darkness after downregulation by optically
controlled iB(RAS) (Fig. 9d, e). This difference is likely originated
from mechanisms underlying RAS-ERK and RAS-Akt regulation,
as the former is regulated mostly through phosphorylation,
whereas the latter may be controlled primarily by transcription
(Fig. 9f, Supplementary Notes 3 and 4).
These results showed that endogenous RAS signaling can be
optogenetically regulated using NIR light and simultaneously
monitored using biosensors for downstream targets operating in
visible-light spectral range, enabling an all-optical assay approach.
This allows functional characterization of the signaling subnet-
works based within their feedback timescales, imperative for
direct interrogation of cellular metabolism46,47.
Discussion
Although recombinant binders of endogenous targets are widely
used in research and therapy, the inability to control them with
high temporal precision leads to off-target activity and requires
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invasive delivery approaches48. To overcome these obstacles, we,
for the first time, incorporated iBs into the BphP1-QPAS1
optogenetic construct, enabling highly specific, fast, and non-
invasive functional regulation of endogenous proteins.
Using an overexpressed protein target (Fig. 1a, b), we first
validated that strong and specific interaction of an iB with the
target suffices to drive the protein relocalization with the kinetics
comparable to that of the original optogenetic construct. This
prompted us to proceed with the designing of an optogenetic
system to control genomically expressed GFP-tagged proteins.
We next demonstrated that the concentration and, hence, the
function of the protein target in a particular cellular compartment
are effectively controlled by light (Fig. 1c–f). Notably, the devel-
oped iB(GFP)-incorporating optogenetic system can be applied to
any GFP-knocked-in cell line in which an endogenous protein is
fused with GFP-like tag, making it the perfect complementary
tool for cell lines generated by CRISPR-Cas9 genome editing29,49.
This optogenetic approach could be multiplexed in terms of
using several iBs of different specificity. Combination of iBs for
different targets would be useful for applications in which the iBs
being inactive individually could trigger a biological process
after the complex formation, as in a case of allosteric inhibition
of Abl50.
We next used a spectral multiplexing of two distinct light-
sensing moieties in iRIS-B (Fig. 2) for dual-wavelength control of
endogenous β-actin (Figs. 3–5). iB(actin) that minimally impacts
actin dynamics51 and iRIS-B were combined to induce measur-
able effects on cellular motility. Our results indicate significant
reduction of overall protrusion–retraction rate under NIR light,
supporting the idea that sequestering endogenous actin at the
plasma membrane slows down the overall rate of cellular mor-
phodynamics driven by actin cytoskeletal rearrangement. The
same iB(actin)-iRIS-B combination illuminated with blue light led
to the increase of nuclear actin pool, followed by the MRTF-A
nuclear export, demonstrating the possibility to regulate multi-
functional proteins using dual-wavelength-controlled optogenetic
systems. Future studies with optogenetically enhanced iB(actin)
could consist of local actin perturbations in lamellipodia, filopo-
dia, podosomes, and tunneling nanotubes, providing further
insights into the role of actin dynamics in these cellular
structures.
Spectral multiplexing of the NIR light-controlled system for
RAS activity with the visible-light ERK and Akt protein kinase
biosensors45 enabled an all-optical assay of endogenous RAS
downstream signaling (Figs. 8 and 9). Monitoring of two distinct
subnetworks of RAS signaling showed the innate difference in
their regulation mechanisms. Likely, the observed dissimilarity in
the recovery kinetics of the RAS-ERK and RAS-Akt subnetworks
suggests a fast feedback control of RAS-ERK by intermediate
kinases, whereas RAS-Akt may be controlled by transcriptional
regulation, exhibiting considerably longer feedback timescales
(Fig. 9f, Supplementary Note 4). It is also possible that Akt could
be directly impacted by other pathways, in addition to RAS,
including PDK1, mTORC2, and protein phosphatases. With the
ability to extend the iB-incorporating optogenetic approach to
any available iB, including for other modulators of Akt activity,
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Fig. 9 All-optical control of endogenous RAS in steady state. a RAS regulation by light in cells expressing EKAR2G2, in serum. Epifluorescence
microscopy; scale bar, 20 µm. Pseudocolor scale: black= 1.0 and white= 2.05. b Normalized whole-cell average FRET/donor ratio in HeLa cells expressing
the optogenetically enhanced iB(RAS) and EKAR2G2 FRET biosensor. n= 3, error bars represent SEM. Source data are provided as a Source Data file.
c Illumination scheme used for the experiments shown in Fig. 9. d RAS-Akt signaling regulation in cells expressing optogenetically controlled iB(RAS).
Representative time-lapse panels of AktAR2 FRET/donor ratio, imaged in HeLa cells in serum. Epifluorescence microscopy; scale bar, 20 µm. Pseudocolor
scale: black= 1.0; white= 2.88. e Normalized whole-cell average FRET/donor ratio as a function of time, in HeLa cells expressing the AktAR2 FRET
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activation. Green: cells with 740 nm illumination starting at t= 300 s time point. Magenta: cells were irradiated with 740 nm light for 2400 s prior to
imaging. f Schematic representation of all-optical control of RAS signaling using iB(RAS). Signaling nodes are shown in gray, optogenetic tools and
biosensors are shown in light gray. Fast negative feedback loops acting via phosphorylation are shown as red dotted lines. Slow feedback loops acting via
transcription inhibition are shown in gray.
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the analyses of cell signaling are now made possible in living cells
by targeting endogenous, unmodified proteins for direct optical
perturbation.
Despite the described optically controlled iBs show the high
potential for regulation of endogenous proteins, several factors
make troubleshooting necessary in its applications. First, the
performance of an iB-based optogenetic tool depends on the
characteristics of the used iB. Hence, the mechanism of action,
affinity and specificity, being the features of iB, are inherited by
the optogenetic tool. It may happen that too strong binding of iB
to its target can increase system leakage in darkness. However,
this can be potentially resolved by adjusting the iB affinity or by
choosing the different iB. Second, the described optogenetic
systems have relatively slow kinetics of thermal relaxation
(switching off). In future, this can be addressed by directed
evolution of light-sensitive proteins into improved versions with
the faster off kinetics. Third, although the bacterial phytochrome-
based optogenetic tools benefit from the abundance of biliverdin
in mammalian cells, they may depend on its concentration in a
particular tissue. This technical obstacle can be overcome by
using stable expression of the phytochrome part of the iB-
incorporating optogenetic tools16.
To summarize, we have demonstrated, for the first time, that
the optogenetically enhanced iBs allow precise regulation of
endogenous proteins otherwise hard-to target with small mole-
cules or genetically encoded probes, which is the case for both
RAS small GTPase14 and β-actin33. Moreover, the developed iB-
based light-control technology may help to reduce side effects of
therapeutic iBs by limiting their action to a specific subcellular
location or a cell type and to a certain time period, avoiding the
undesirable influence on healthy cells and tissues.
Methods
Design of plasmids. The plasmids designed in this study are summarized in
Supplementary Table 1. Mammalian vectors used in this study used plasmids
designed by us earlier as templates16. Anti-GFP nanobody vhhGFP4, referred in
this paper as “anti-GFP iB” or “iB(GFP)” was from pcDNA3_NSlmb-vhhGFP4, a
gift from M. Affolter (Addgene plasmid #35579). pQP-2376 was used as an
intermediate cloning step, NSImb domain was further removed, to get pQP-2460.
Vector containing PiggyBac52 terminal repeats and EGFP-PAC under CMV pro-
moter, as well as vector for hyperactive PiggyBac transposase expression were
constructed by VectorBuilder (Cyagen Biosciences). pLentiEKAR2G2 was a gift
from O. Pertz (Addgene plasmid #40178). pcDNA3-AktAR2 was a gift from J.
Zhang (Addgene plasmid #64932). GFP-ERK2 was a gift from R. Seger (Addgene
plasmid #37145). mEGFP-HRAS plasmid was a gift from K. Svoboda (Addgene
plasmid #18662). Anti-RAS monobody NS1, referred in this paper as “iB(RAS)”
was synthetized by GenScript, using amino acid sequence from 5E95 Protein Data
Bank entry for reverse translation53. Actin chromobody, referred in this paper as
“iB(actin)” is commercially available from ChromoTek.
Mammalian cell culture and transfection. HeLa cells were purchased from the
ATCC (CCL-2) and were not additionally authenticated or tested for mycoplasma
contamination. Cells were grown in DMEM medium supplemented with 10% FBS,
penicillin-streptomycin mixture (all from Gibco) at 37 °C. For experiments, cells
were plated on six-well plates (Greiner Bio-One). Transient transfections were
performed using an Effectene transfection reagent (Qiagen). The culture medium
was changed 6 h after the transfection with the new one containing 25 μM of BV.
Preclonal mixtures of HeLa cells were obtained using the plasmid-based PiggyBac
transposon system. For this, the EGFP-PAC under CMV promoter was cloned into
the transposon bearing plasmids pQP-EGFP-PAC and cotransfected with a plas-
mid encoding a hyperactive PiggyBac transposase, in 1 (transposon):3 (transpo-
sase) ratio. Cells were further selected with 3 µg/ml of puromycin (InvivoGen) for
2 weeks resulting in the preclonal HeLa cell mixtures stably expressing EGFP-PAC.
For EKAR2G2 (Addgene #40178) and AKTAR2 (Addgene #64932) biosensor
experiments, HeLa cells were transiently transfected together with pQP-AR10
(Supplementary Table 1) construct at DNA ratio of 1: 1. For iB(actin)–iRIS-B
experiments, HeLa cells were transiently transfected with iB(actin), stands for actin
chromobody (ChromoTek), and iRIS-B DNA at a ratio of 1:3. Cell transfections
were performed by using PEI (ref. 54) and Fugene HD (Promega) reagents
following the manufacturer’s protocols. HeLa cells were trypsinized and plated
onto 6-well dishes at 1.5 × 105 cells per well on the morning of transfection. Two
hours after plating, transfection was performed with total DNA of 2 µg/well. Six
hours following transfection, media was supplemented with 25 µM BV and
incubated overnight. Live-cell imaging experiments were performed starting at 24 h
post transfection. Recombinant human EGF (Thermo Fisher, PHG0315) was used
for acute stimulation, at final concentration of 25 ng/ml (4 nM).
For nuclear actin regulation studies, 2 days prior to the experiment, human
osteosarcoma (U2OS) cells were seeded on coverslips with DMEM supplemented
with 10% FBS. Next day, the cells were transfected with iRIS-B and actin
chromobody (ChromoTek) 2:1 ratio using JetPrime (Polyplus-Transfection)
transfection reagent according to the manufacturer’s protocol. Eight hours after
transfection, the media was changed to DMEM with 0.3% FBS and 25 µM of BV to
introduce serum starvation. After 16 h in starvation, the cells were either
illuminated with 460 nm light (1 mW cm−2) or kept in darkness for 30 min. FBS
was then added to the media to raise the total FBS concentration to 15% in order to
cause serum stimulation. Cells were fixed with 4% paraformaldehyde after 1 min of
serum stimulation.
Cell light activation and imaging. Imaging was performed using an Olympus
IX83 inverted epifluorescence microscope equipped with a 200W metal halide
(Lumen 220PRO, Prior) or a xenon-arc (Lambda LS, Sutter) lamps. An OptiMOS
sCMOS (QImaging) or an ORCA-Flash4.0 V3 (Hamamatsu) cameras were used
for image acquisition. Unless otherwise indicated, cells were imaged using either a
40×, 0.95 NA air or a 60 × 1.35 NA oil objective lens (UPlanSApo, Olympus). HeLa
cells imaging was performed in a live-cell imaging solution (Invitrogen, A14291DJ)
at 37 °C. CELLview glass‐bottomed dishes (Greiner Bio‐One) were used for ima-
ging. Confocal imaging was performed by using a Leica TCS SP8 microscope
equipped with a 63 × 1.4 NA, and HC PL APO CS2 objective and a white light laser
(470–670 nm).
For the relocalization assays, NIR or blue (both 1 mW cm−2) illumination was
applied by using the custom‐assembled LED arrays (LED Engin), 460/20 and 740/
25 nm respectively. Focusing of the microscope was performed in mCherry channel
to prevent unspecific activation of blue‐ and NIR‐light‐sensing components. A
pulsed illumination (10 min 740 nm/30 min darkness) was used for a long-term
survival assay.
The data were analyzed using a SlideBook v. 6.0.8 (Intelligent Imaging
Innovations), a Fiji v. 1.50b (ref. 55) and an OriginPro v. 8.6 (Origin Labs) software.
Images were appropriately scaled for meaningful representation. Specifically, a
lookup table altering was performed for reduction of background signal; a maximal
signal value specification and a nonlinear correction (gamma in the range of 0.8–1)
was performed to avoid picture oversaturation, if necessary. Unless indicated to the
contrary, a single Z-section is shown. No deconvolution techniques were used.
Importantly, for all types of quantification, such as (i) intensity measurements, (ii)
profiles plotting, and (iii) colocalization analysis, the uncompressed and
unmodified 16-bit TIFF images were used. A Savitzky–Golay denoising (points of
window= 60, polynomial order= 2) was applied to intensity profiles using an
OriginPro v. 8.6 software (Origin Labs). Time-lapse images were combined in
stacks and aligned using a rigidbody registration algorithm. To measure the
kinetics of fluorescence intensity, at least eight separate regions of interest in the
cytoplasm or in the nucleus were chosen for each cell. The background
fluorescence was subtracted from the mean fluorescence intensity for each time
point, and the intensity levels were normalized to the initial fluorescence and
plotted. Fluorescence intensity profiles were determined using an ImageJ software.
Image analysis for quantification of fluorescence associated with the plasma
membrane was performed using the NumPy array operations, morphological
operations, filtering from SciPy, and plotting from Matplotlib, all available from an
Anaconda python distribution (v. 2019.03).
For MRTF-A relocalization experiments cells were imaged using Leica TSC SP8
confocal microscope (Leica Microsystems) with HC PL APO 93 × 1.3 NA glycerol
objective. Confocal sections from the middle of the cells were recorded and
the intensity was measured from both the nucleus and the cytoplasm with 40 ×
40 pixels circle selection using FIJI. The ratio between the nucleus and the
cytoplasm was calculated and average ratios plotted with standard error of the
mean (SEM).
Fixed samples preparation and immunostaining. HeLa cells transfected with
pQP-AR10 were cultured on coverslips, coated with poly-L-lysine (Merck, A-005-
C) and (i) kept in darkness, (ii) illuminated by 740 nm light (30 min), or (iii)
preilluminated by 740 nm light (30 min) with following recovery period (30 min in
darkness). After this, cells were fixed with 4% paraformaldehyde for 10 min at
room temperature, washed three times with PBS, and permeabilized for 15 min
with 0.5% Tween 20. After blocking with 1% BSA in PBS containing 0.1% Tween
20 (PBST, 1 h) cells were incubated with primary Anti-Pan-Ras antibody, mouse
monoclonal IgG2aκ, clone RAS 10 (MABS195, Merck), 1:500 dilution, for 1 h, in
1% BSA in PBST. Further, coverslips were washed and incubated with secondary
Alexa Fluor 488‐conjugated antibody, anti-mouse goat IgG (Thermo Fisher, A-
11001) for 1 h in 1% BSA in PBST, then washed and mounted using mounting
medium containing DAPI (Santa Cruz). For nuclear actin regulation studies, fixed
cells were stained with MRTF-A antibody (G-8, sc-390324, Santa Cruz Bio-
technology), 1:500 dilution, followed by anti-mouse Alexa Fluor 647 secondary
antibody (Thermo Fisher) and DAPI.
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Imaging of FRET biosensor and the optogenetic tool. HeLa cells transfected
with the biosensor and pQP-AR10 were plated onto 25 mm no. 1.5 coverslips
coated with fibronectin (10 µg/ml), under normal culture conditions without BV
and in the dark for 3 h prior to imaging. Cells were transferred to imaging medium
consisting of Ham’s F-12K without phenol red, supplemented with 3% FBS, argon
gas sparged, and treated with Oxyfluor reagent with 5 mM NaC3H5O3 (www.
oxyrase.com). FRET imaging was performed following previously described
methods56. Briefly, coverslips containing cells were mounted onto a temperature
regulated sealed chamber system57 atop a widefield epifluorescence Olympus IX81-
ZDC microscope (Olympus). Cells were imaged through a ×40 magnification
objective lens (Olympus UIS 40 × 1.3 N.A.), illuminated with light from a 100W
Hg arc lamp via an excitation filter ET436/20X (Chroma Technology). Fluores-
cence emission was routed through an external beamsplitter via an T505LPXR
(Chroma Technology) that separated the FRET and CFP channels, and captured
simultaneously via two independently mounted CoolSnapES2 cameras (Photo-
metrics) through bandpass filters ET480/40M for CFP and ET535/30M for FRET
(Chroma Technology). For optogenetic activation, 75W Xe arc lamp was used to
illuminate through a bandpass filter HQ745/45X (Chroma Technology) and was
combined with the main fluorescence excitation light train via a long-pass mirror
T650LPXXRU (Chroma Technology). The illumination shutter for the optogenetic
activation was controlled manually as required during the imaging experiment to
irradiate the whole field with the far-red excitation light. Images were acquired at
10 s intervals for the given duration of time per experiment. For data analysis,
FRET and donor channel images were camera noise-, background-, and flatfield
corrected56. The two channels were then processed for proper alignment using a
priori calibration and a nonlinear coordinate transformation approach to achieve
pixel-to-pixel matching required for ratiometric analysis56. Cell images were
thresholded based on the intensity histogram to select the foreground region from
the background, binary masks were created, and multiplied into the cell images to
achieve segmentation of the data. These images were then x–y translationally
aligned58, and the FRET channel was divided by the CFP channel to result in
ratiometric data. A linear lookup table was applied that corresponded to relative
biosensor activity levels within a cell.
Cell area change quantification. For iB(actin)+ iRIS-B analysis, HeLa cells
expressing iB(actin) and iRIS-B were plated onto fibronectin (10 µg/ml) coated 25
mm #1.5 coverslips and allowed to attach for 3 h under normal culture conditions
(without BV) in the dark prior to imaging. Cells were transferred to imaging
medium consisting of Ham’s F-12K without phenol red, supplemented with 10%
FBS, argon gas sparged, and treated with Oxyfluor reagent with 5 mM NaC3H5O3
(www.oxyrase.com). Coverslips containing cells were mounted onto a temperature
regulated sealed chamber system, and imaged at 10 s intervals for designated
amount of time. GFP channels were acquired once at the beginning of the time-
lapse series and once at the end, to minimize any spurious activation of LOV2-
domain built into the iRIS-B system. The optogenetic activation was performed by
manually switching on the activation light at a time point between the 60th and the
61st frames. Imaging was continued for 180 frames (30 min) following the opto-
genetic activation. The morphometric parameters of a cell were calculated fol-
lowing the tracking of cell edge using the Morphodynamics software package59,60.
Briefly, intensity thresholding was used to construct segmentation masks of the cell
images at every time point in time-lapse movies, using the mCherry fluorescence
channel. The cell edges were determined automatically from these binary masks at
every time point by tracking the position of edges over time by using a previously
described software59,60 (Supplementary Fig. 8). The cell area within a given region
of interest at a given time point in a time series was determined to be the number of
positive intensity pixels from the edge of the image frame to that terminating at the
tracked edge location per frame. The absolute rate of cell area change was calcu-
lated by taking the absolute value of the time differential of the cell area data (this
accounted for both expansion and the shrinkage of cell area; thus, characterizing
the total ability of a cell to mobilize the cell edge). The data were then averaged
within 10 min bins (60 frame differentials) and ratios of experimental (iB(actin)
with iRIS-B) to control (iRIS-B only) conditions were calculated within those 10
min bins of average values.
Reproducibility. The experiments were not randomized. The investigators were
not blinded to allocation during the experiments and outcome assessment. No
sample-size estimation was performed to ensure adequate power to detect a pre-
specified effect size.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The main data supporting the findings of this study are available within the article and its
Supplementary Materials. The source data underlying Fig. 3d–f, 5b, g, 6c, d, g, 8a, c, and
9b, e, and Supplementary Figs. 1a–f, 3b, c, 4b–g, 11a, b, and 12 are provided as a Source
Data file. The additional data are available from the corresponding author on reasonable
request.
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